Add to ORKGhepatitis B reactivation in patients with cancer who test positive for hepatitis B surface antigen (HBsAg) and are undergoing chemo-therapy. Purpose: To determine whether preventive lamivudine reduces chemotherapy-induced hepatitis B virus (HBV)–related morbidity and mortality in patients with cancer who test positive for HBsAg
Three strategies using lamivudine have been proposed to prevent chemotherapy-induced HBV (hepatitis ...
Hepatitis B virus (HBV) reactivation is the frequent complication after cytotoxic chemotherapy in HB...
Background: Solid tumor chemotherapy regimens pose a riskfor hepatitis B virus (HBV) reactivation, b...
Hepatitis B virus (HBV) reactivation is a serious clinical problem in HBV carriers undergoing chemot...
Lamivudine is effective to control hepatitis B virus (HBV) reactivation in HBV-carrying cancer patie...
[[abstract]]Purpose: Prophylactic lamivudine to prevent chemotherapy-induced hepatitis B virus (HBV)...
[[abstract]]Lamivudine is effective to control hepatitis B virus (HBV) reactivation in HBV-carrying ...
Backgound: A significant proportion of hepatitis B surface antigen (HBsAg) negative/anti-hepatitis B...
Background/PurposeLamivudine has been recommended as prophylaxis for the reactivation of hepatitis B...
Lamivudine prophylaxis is an effective strategy in HbSAg-positive patients receiving cancer chemothe...
Prophylactic antiviral therapy is essential for lymphoma patients with high baseline HBV DNA who und...
. During chemotherapy for lymphoma, the administration of cytotoxic agents and rituximab often resul...
Patients diagnosed with hematology malignancy and solid tumor who underwent chemotherapy, frequently...
<div><p>Background</p><p>Three strategies using lamivudine have been proposed to prevent chemotherap...
Nucleos(t)ide analogues reduce the incidence of hepatitis B virus (HBV) reactivation in cancer patie...
Three strategies using lamivudine have been proposed to prevent chemotherapy-induced HBV (hepatitis ...
Hepatitis B virus (HBV) reactivation is the frequent complication after cytotoxic chemotherapy in HB...
Background: Solid tumor chemotherapy regimens pose a riskfor hepatitis B virus (HBV) reactivation, b...
Hepatitis B virus (HBV) reactivation is a serious clinical problem in HBV carriers undergoing chemot...
Lamivudine is effective to control hepatitis B virus (HBV) reactivation in HBV-carrying cancer patie...
[[abstract]]Purpose: Prophylactic lamivudine to prevent chemotherapy-induced hepatitis B virus (HBV)...
[[abstract]]Lamivudine is effective to control hepatitis B virus (HBV) reactivation in HBV-carrying ...
Backgound: A significant proportion of hepatitis B surface antigen (HBsAg) negative/anti-hepatitis B...
Background/PurposeLamivudine has been recommended as prophylaxis for the reactivation of hepatitis B...
Lamivudine prophylaxis is an effective strategy in HbSAg-positive patients receiving cancer chemothe...
Prophylactic antiviral therapy is essential for lymphoma patients with high baseline HBV DNA who und...
. During chemotherapy for lymphoma, the administration of cytotoxic agents and rituximab often resul...
Patients diagnosed with hematology malignancy and solid tumor who underwent chemotherapy, frequently...
<div><p>Background</p><p>Three strategies using lamivudine have been proposed to prevent chemotherap...
Nucleos(t)ide analogues reduce the incidence of hepatitis B virus (HBV) reactivation in cancer patie...
Three strategies using lamivudine have been proposed to prevent chemotherapy-induced HBV (hepatitis ...
Hepatitis B virus (HBV) reactivation is the frequent complication after cytotoxic chemotherapy in HB...
Background: Solid tumor chemotherapy regimens pose a riskfor hepatitis B virus (HBV) reactivation, b...